MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,208,534
EPS
-$0.03
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
General and administrative expenses
450,330
578,698
5,328,284
904,346
Research and development expenses
705,789
524,781
496,543
412,639
Total operating costs
1,156,119
1,103,479
5,824,827
1,316,985
Interest income
35,130
44,909
51,820*
15,697
Other expense
-
-
-24,251*
12,441
Loss from equity method investment related party
-87,545
-91,582
-234,565*
176,056
Other income, expense, net
-
-
-
179,312
Total other (expense) income, net
-52,415
-46,673
-158,494
-
Net loss
-1,208,534
-1,150,152
-5,983,321
-1,137,673
Deemed dividend
-
-
0
21,556,821
Net gain attributable to common stockholders
-
-
-5,983,321
-22,694,494
Basic EPS
-0.03
-0.03
-0.143
-1.18
Diluted EPS
-0.03
-0.03
-0.338*
-1.18
Basic Average Shares
42,022,087
41,941,370
41,870,778
19,274,947
Diluted Average Shares
-
-
-
19,274,947
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$1,208,534
(21.41%↑ Y/Y)
Total operating costs
$1,156,119
(-25.22%↓ Y/Y)
Total other (expense)
income, net
-$52,415
(-48885.98%↓ Y/Y)
Interest income
$35,130
(313.54%↑ Y/Y)
Research and development
expenses
$705,789
(42.24%↑ Y/Y)
General and
administrative expenses
$450,330
(-57.11%↓ Y/Y)
Loss from equity
method investment ...
-$87,545
Buy us a coffee
MIRA PHARMACEUTICALS, INC. (MIRA)
MIRA PHARMACEUTICALS, INC. (MIRA)